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Abstract
Background: Topical negative pressure (TNP), widely used in wound therapy, is known to
stimulate wound edge blood flow, granulation tissue formation, angiogenesis, and revascularization.
We have previously shown that application of a TNP of -50 mmHg to the myocardium significantly
increases microvascular blood flow in the underlying tissue. We have also shown that a myocardial
TNP levels between -75 mmHg and -150 mmHg do not induce microvascular blood flow changes
in the underlying myocardium. The present study was designed to elucidate the difference between
-25 mmHg and -50 mmHg TNP on microvascular flow in normal and ischemic myocardium.
Methods:  Six pigs underwent median sternotomy. The microvascular blood flow in the
myocardium was recorded before and after the application of TNP using laser Doppler flowmetry.
Analyses were performed before left anterior descending artery (LAD) occlusion (normal
myocardium), and after 20 minutes of LAD occlusion (ischemic myocardium).
Results: A TNP of -25 mmHg significantly increased microvascular blood flow in both normal
(from 263.3 ± 62.8 PU before, to 380.0 ± 80.6 PU after TNP application, * p = 0.03) and ischemic
myocardium (from 58.8 ± 17.7 PU before, to 85.8 ± 20.9 PU after TNP application, * p = 0.04). A
TNP of -50 mmHg also significantly increased microvascular blood flow in both normal (from 174.2
± 20.8 PU before, to 240.0 ± 34.4 PU after TNP application, * p = 0.02) and ischemic myocardium
(from 44.5 ± 14.0 PU before, to 106.2 ± 26.6 PU after TNP application, ** p = 0.01).
Conclusion: Topical negative pressure of -25 mmHg and -50 mmHg both induced a significant
increase in microvascular blood flow in normal and in ischemic myocardium. The increase in
microvascular blood flow was larger when using -25 mmHg on normal myocardium, and was larger
when using -50 mmHg on ischemic myocardium; however these differences were not statistically
significant.
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Background
TNP promotes wound healing by stimulating wound edge
blood flow, as has been shown in both peripheral [1] and
in skeletal muscle in sternotomy wounds[2]. TNP pro-
duces a mechanical stress and a pressure gradient across
the tissue which may cause a surge of blood to the area.
Mechanical forces and increased blood flow are known to
stimulate granulation tissue formation, i.e. endothelial
proliferation, capillary budding and angiogenesis[3,4].
Poststernotomy mediastinitis is a strong predictor for
poor long-term survival after coronary artery by-pass sur-
gery (CABG), when using conventional wound healing
techniques (closed irrigation, delayed wound closure, or
reconstructing with omentum or pectoral flaps)[5,6].
Braxton and coworkers demonstrated that actuarial sur-
vival after 10 years was 39% in patients with poststernot-
omy mediastinitis and 70% in patients without
mediastinitis[6]. Milano and collages have suggested that
mediastinitis may cause negative long-terms effects on
several organs such as the heart and kidneys[5]. Lately, the
usefulness of TNP in the treatment of poststernotomy
mediastinitis has been well recognized among cardiotho-
racic surgeons around the world, due to excellent clinical
outcome[7,8].
Previously, we have showed no difference in long-term
survival between CABG patients with TNP-treated medias-
tinitis and CABG patients without mediastinitis[9]. This
might indicate that these patients have developed
increased coronary collateral blood vessels during TNP,
since the anterior part of the heart is in direct contact with
the negative pressure source during TNP treatment, and
they might therefore be better prepared when bypass
grafts fail to work. It may be that the TNP stimulation of
blood flow and development of collateral blood vessels in
part account for the reduced long-term mortality in those
patients.
Earlier, we have showed that a TNP of -50 mmHg signifi-
cantly increases microvascular blood flow in normal,
ischemic, and reperfused porcine myocardium[10]. We
have also demonstrated that TNP levels between -75
mmHg and -150 mmHg do not induce microvascular
blood flow changes in normal nor ischemic porcine myo-
cardium[11]. When applying TNP to subcutaneous tissue
and skeletal muscle, a relative zone of hypoperfusion is
seen close to the vacuum source. The size of the zone
depends on tissue density, the amount of negative pres-
sure applied, and the distance from the vacuum
source[12]. We believe that application of a TNP of -150
mmHg results in hypoperfusion 6–8 mm down into the
ischemic myocardium, which would explain previous
findings[11]. A large zone of hypoperfusion in the myo-
cardium would, theoretically lead to ischemia in those
parts of the myocardium, and would, potentially cause
damage to the heart.
The aim of this study was thus to elucidate the differences
between negative pressures of -25 mmHg and -50 mmHg.
Microvascular blood flow was measured in a porcine
model using laser Doppler flowmetry. The effects of TNP
of -25 mmHg and -50 mmHg on microvascular blood
flow were investigated in the myocardium before (normal
myocardium) and during occlusion of the left anterior
descending artery (LAD) (ischemic myocardium) to imi-
tate an ischemic coronary artery disease.
Methods
Experimental animals
A porcine model was use for the present study. Six domes-
tic landrace pigs of both genders, with a mean body
weight of 70 kg, were fasted overnight with free access to
water. The study was approved by the Ethics Committee
for Animal Research, Lund University, Sweden. The inves-
tigation complied with the "Guide for the Care and Use of
Laboratory Animals" as recommended by the U.S.
National Institutes of Health, and published by the
National Academies Press (1996).
Anesthesia
All the animals were pre-medicated intramuscularly with
ketamine (30 mg/kg) before they were brought into the
laboratory. Before commencing surgery, sodium thiopen-
tal (5 mg/kg), atropine (0.02 mg/kg) and pancuronium
(0.5 mg/kg) were given intravenously. Tracheotomy was
performed with a Portex endo-tracheal tube (7.5 mm
internal diameter, Medcompare™, USA). A servo-ventila-
tor (Siemens Elema 300A, Stockholm, Sweden) was used
for mechanical ventilation throughout the experiment.
The ventilator settings used were: minute volume = 100
ml/kg, FiO2 = 0.5, breathing frequency = 16 breaths/
minute and positive end expiratory pressure = 5 cmH2O.
Anesthesia and muscular paralysis were maintained by
continuous intravenous infusion of Diprivan® (propofol,
AstraZeneca, Sweden) 8–10 mg/kg/hour, Leptanal® 0.15
mg/kg/hour (fentanyl, Lilly, France) and Pavulon® 0.6
mg/kg/hour (pancuronium, Organon Teknika, Boxtel, the
Netherlands).
Data acquisition
Mean arterial pressure, central venous pressure, body tem-
perature, and ventilator parameters were recorded
throughout the experiments.
Surgical procedure
Surgery was performed through median sternotomy. After
heparinization (400 IU/kg) a cardiopulmonary bypass
(CPB) was installed with an arterial cannula (22 French,BMC Cardiovascular Disorders 2008, 8:14 http://www.biomedcentral.com/1471-2261/8/14
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DLP®  Elongated One-Piece Arterial Cannula (EOPA™),
Medtronic Inc., Minneapolis, MO, USA) in the distal
ascending aorta, and a venous cannula (32 French, MC2®
Two-Stage Venous Cannula, Medtronic Inc.) inserted
through the right atrium. Before cannulation of the heart
the cannulae were inserted through the thoracic wall to
prevent air leakage during TNP application. CPB was con-
ducted in normothermia. Ventricular fibrillation was sub-
sequently induced in the heart. No aortic cross-clamping
was performed and no cardioplegia was employed. The
mean arterial pressure was maintained between 60 and 80
mmHg. A left ventricular vent (DLP® Vent, Medtronic Inc.)
was used to protect the left chamber from overloading.
Pulmonary ventilation was applied at 4 liters/minute dur-
ing the experiments.
CPB was used to facilitate the measurement of microvas-
cular blood flow using laser Doppler flowmetry. Fibrilla-
tion of the heart minimizes the movement artifacts, while
the physiological conditions are, to a large extent, con-
served. Moreover, CPB prevents the risk of circulatory fail-
ure during LAD occlusion, thereby facilitating
experimental analysis in the ischemic myocardium.
Microvascular blood flow was measured by laser Doppler
flowmetry (Peri Flux System 5000, Perimed, Stockholm,
Sweden), using a technique that quantifies the sum of the
motion of the red blood cells in a specific volume, exten-
sively applied in plastic surgery procedures[13]. In this
method, a fiber optic probe carries a beam of light. Light
impinging on cells in motion undergoes a change in
wavelength (Doppler shift) while light impinging on
static objects remains unchanged. The magnitude and fre-
quency distribution of the changes are directly related to
the number and velocity of red blood cells. The informa-
tion is collected by a returning fiber, converted into an
electronic signal and analyzed.
Laser Doppler probes were inserted horizontally into the
heart muscle 6–8 mm lateral of the LAD at depths of
approximately, 6–8 mm. The mean thickness of the cham-
ber wall was approximately 20–25 mm. All probes were
carefully fixed to the surface of the heart with a suture
(Prolene 7-0; Ethicon Inc., Somerville, NJ, USA), thereby
preventing the probe from sliding. A round hole with a
diameter of 5 cm was made in the middle of a Phrenic
Nerve Pad®(Medtronic Inc.) and placed on top of the
heart. The pad was stabilized to the surrounding myocar-
dium with 8–10 sutures (Prolene 5-0; Ethicon Inc.) and to
the posterior sternal edges with sutures (Dermalon 2-0;
Davis and Geck, St Louis, MO, USA). A retractor was used
throughout the experiments to keep the sternal edges
apart. A polyurethane foam dressing, with an open pore
structure of 400 to 600 μm (KCI, Copenhagen, Denmark)
was placed between the sternal edges. The foam was con-
tinuously sutured to the surrounding skin (Dermalon 2-0;
Davis and Geck). The wound was then sealed with a trans-
parent adhesive drape. A track pad (KCI) was inserted
through the drape and was connected to a continuous vac-
uum source, (V.A.C. pump unit, KCI). When the negative
pressure is applied, the heart will be drawn up towards the
phrenic nerve pad and the foam without interfering with
the sternal edges. This procedure causes the application of
negative pressure to affect only the myocardium exposed
by the 5 cm diameter hole. After the experiment the heart
was dissected to confirm probe location.
Experimental protocol
The microvascular blood flow was measured continu-
ously by the laser Doppler filament probes. Recordings
were made in normal myocardium before and after nega-
tive pressures of -25 or -50 mmHg were applied. In animal
1, 3, and 5 the negative pressure of -25 mmHg was applied
before the negative pressure of -50 mmHg was applied.
The baseline was restored between the two settings. In ani-
mal 2, 4, and 6 the negative pressure of -50 mmHg was
applied before the negative pressure of -25 mmHg was
applied. The baseline was restored between the two set-
tings.
The LAD was then occluded for 20 minutes with an elastic
vessel loop. Microvascular blood flow was measured
before, and after 20 minutes of occlusion.
Recordings were also made in ischemic myocardium,
before and after negative pressures of -25 or -50 mmHg
were applied. In animal 1, 3, and 5 the negative pressure
of -25 mmHg was applied before the negative pressure of
-50 mmHg was applied. The baseline was restored
between the two settings. In animal 2, 4, and 6 the nega-
tive pressure of -50 mmHg was applied before the nega-
tive pressure of -25 mmHg was applied. The baseline was
restored between the two settings.
Calculation and statistics
Laser Doppler flowmetry measurements were performed
on six pigs. The output was continuously recorded using
PeriSoft software (Perimed, Stockholm, Sweden). Microv-
ascular blood flow was expressed in terms of perfusion
units (PU). Calculations and statistical analysis were per-
formed using GraphPad 4.0 software. Statistical analysis
was performed using Student's paired t-test, and signifi-
cance was defined as ***p < 0.001, **p < 0.01, *p < 0.05,
and p > 0.05 (not significant, n.s.). Values are presented as
means ± the standard error on the mean (SEM).
Results
Normal myocardium
A topical negative pressure of -25 mmHg significantly
increased microvascular blood flow in normal myocar-BMC Cardiovascular Disorders 2008, 8:14 http://www.biomedcentral.com/1471-2261/8/14
Page 4 of 7
(page number not for citation purposes)
dium (from 263.3 ± 62.8 PU before, to 380.0 ± 80.6 PU
after TNP application, * p = 0.03). A TNP of -50 mmHg
also significantly increased microvascular blood flow in
normal myocardium (from 174.2 ± 20.8 PU before, to
240.0 ± 34.4 PU after TNP application, * p = 0.04) (Figure
1).
LAD occlusion
Ischemia was induced by occlusion of the LAD for 20
minutes. The blood flow was 235.4 ± 37.4 PU before
occlusion of the LAD and decreased to 52.1 ± 11.1 PU
after 20 minutes of LAD occlusion (*** p = 0.003) (Figure
2).
Ischemic myocardium
A topical negative pressure of -25 mmHg significantly
increased microvascular blood flow in ischemic myocar-
dium (from 58.8 ± 17.7 PU before, to 85.8 ± 20.9 PU after
TNP application, * p = 0.02). A TNP of -50 mmHg also sig-
nificantly increased microvascular blood flow in ischemic
myocardium (from 44.5 ± 14.0 PU before, to 106.2 ± 26.6
PU after TNP application, ** p = 0.01) (Figure 3).
Discussion
Poststernotomy mediastinitis is a strong predictor for
poor long-term survival after coronary artery by-pass graft-
ing (CABG) [5,6]. Braxton and coworkers demonstrated
that actuarial survival after 10 years was 39% in patients
with poststernotomy mediastinitis and 70% in patients
without mediastinitis[6]. Milano and collages have sug-
gested that mediastinitis may cause negative long-terms
effects on several organs such as the heart and kidneys[5].
Theoretically, a massive immunological response during a
prolonged period of infection may cause adverse effects
on by-pass grafts. In those studies, reporting poor long-
term survival after mediastinitis, several conventional
wound healing techniques were used (closed irrigation,
delayed wound closure, or reconstructing with omentum
or pectoral flaps). Interestingly, Sjogren and coworkers,
found no difference in long-term survival between CABG
patients with TNP-treated mediastinitis and CABG
patients without mediastinitis [9]. During the treatment
of poststernotomy mediastinitis, the topical negative pres-
sure is in direct contact with the heart, which is exposed
through the diastase of the sternotomy. These patients
may therefore have developed increased coronary collat-
eral blood vessels during TNP, and may be better prepared
when bypass grafts fail to work. We have indeed observed
in patients treated with TNP, that richly vascularized gran-
ulation tissue develops over the heart within 8–10 days. It
may well be that the stimulation of blood flow and the
development of collateral blood vessels resulting from
TNP in part account for the reduced long-term mortality
in patients treated in this way.
TNP has become the therapy of choice in the treatment of
chronic and problematic wounds at many hospitals
worldwide, due to excellent clinical outcome[9,14].
Despite the extensive clinical use and excellent outcome
of TNP in wound therapy, the fundamental scientific
Microvascular blood flow measured using laser Doppler  flowmetry in the myocardium before and after 20 minutes of  occlusion of the left anterior descending artery (LAD) Figure 2
Microvascular blood flow measured using laser Dop-
pler flowmetry in the myocardium before and after 
20 minutes of occlusion of the left anterior descend-
ing artery (LAD). The measurements were performed at a 
depth of 6–8 mm in the myocardium in six pigs. The results 
are shown as mean values ± SEM in the left panel. A level of 
*p < 0.05, **p < 0.01, and ***p < 0.001 was considered statis-
tically significant. The right panel shows a representative 
example of microvascular blood flow changes before and 
after occlusion of the LAD
Microvascular blood flow measured using laser Doppler  flowmetry in normal myocardium exposed to topical nega- tive pressures of -25 mmHg and -50 mmHg Figure 1
Microvascular blood flow measured using laser Dop-
pler flowmetry in normal myocardium exposed to 
topical negative pressures of -25 mmHg and -50 
mmHg. The measurements were performed at a depth of 
6–8 mm in the myocardium in six pigs. The results are shown 
as mean values ± SEM in the left panel. A level of *p < 0.05, 
**p < 0.01, and ***p < 0.001 was considered statistically sig-
nificant. The right panel shows a representative example of 
microvascular blood flow changes before and after applica-
tion of -50 mmHg. Note the immediate blood flow response 
when negative pressure is applied.BMC Cardiovascular Disorders 2008, 8:14 http://www.biomedcentral.com/1471-2261/8/14
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mechanism is only partly understood. The known effects
of TNP are enhanced blood flow to the wound edge and
granulation tissue formation [15,16]. TNP increases
blood flow velocity and opens up the capillary beds. The
mechanical force (vacuum force) exerted by TNP and
increased blood flow and shear stress against the vessel
walls, which affect the cytoskeleton in the vascular cells,
stimulating endothelial proliferation and angiogen-
esis[3,17]. TNP has recently been shown to increase ang-
iogenesis and decrease matrix metalloproteinases both of
which promote new vessel formation [4].
In a previous report we applied a TNP of -50 mmHg over
the LAD region on six pigs, and was able to show a signif-
icant increase in microvascular blood flow in normal
myocardium (non-ischemic myocardium), in ischemic
myocardium after 20 minutes of LAD occlusion, and also
in reperfused myocardium (former ischemic myocardium
after 20 minutes of reperfusion)[10]. In another previous
report we show that pressure levels between -75 and -150
mmHg did not induce any significant microvascular
blood flow changes in normal neither ischemic myocar-
dium[11]. When applying negative pressure to subcutane-
ous tissue and skeletal muscle, a relative zone of
hypoperfusion is seen close to the vacuum source. The
size of the hypoperfusion zone depends on tissue density,
the amount of negative pressure applied, and the distance
from the vacuum source[12]. We believe that pressure lev-
els above -75 mmHg results in vasoconstriction 6–8 mm
down into the underlying myocardium, which would
explain previous findings[11]. A large zone of vasocon-
striction in the myocardium would, theoretically lead to
ischemia in those parts of the myocardium, and would,
potentially cause damage to the heart. Theoretically, the
most beneficial topical negative pressure, to use on the
myocardium, should be as low as possible, to avoid a
zone of vasoconstriction. Moreover, the negative pressure
has to be high enough to create a vacuum force big
enough to cause a significant increase in the microvascu-
lar blood flow in the underlying myocardium. In the
present study we show that a myocardial topical negative
pressure of -25 mmHg results in an increase in microvas-
cular blood flow in the underlying tissue in both normal
and ischemic myocardium. We also show that a myocar-
dial topical negative pressure of -50 mmHg results in a
microvascular blood flow increase (normal and ischemic
myocardium), as shown in prior study[11]. Moreover, the
increase in microvascular blood flow was larger when
using a TNP of -25 mmHg on normal myocardium, and
was larger when using a TNP of -50 mmHg on ischemic
myocardium, however these differences were not statisti-
cally significant, and might therefore be analyzed with
caution. From our perspective a topical negative pressure
of -50 mmHg might be more favourable as optimal myo-
cardial TNP than -25 mmHg.
In the present study, CPB was used, which facilitated the
intervention since arrhythmia and circulatory failure were
avoided during the induction of ischemia. Laser Doppler
flowmetry is a well established method that provides con-
tinuous recording of the microvascular blood flow. To use
laser Doppler on a beating heart is complex. Every heart
beat provides a movement that will become registered by
the laser Doppler flowmetry[18]. The movement artifact
of the laser Doppler flow curve becomes very large and the
data collected becomes difficult to analyze. The experi-
ment was conducted during low intense ventricular fibril-
lation to minimize movement artifacts from heart beats,
and minimize tissue trauma, and sliding of the laser Dop-
pler probes, while measuring blood flow in the myocar-
dium[18]. Moreover, ventricular fibrillation does differ
from sinus rhythm. During ventricular fibrillation there is
no synchronized contraction in the ventricles. If perfusion
pressure is kept above 50 mmHg the ventricular wall will
still be perfused[19], but the myocardial wall tension may
become higher than in a beating heart[20]. Hottenrot et
al. showed in 1972 that perfusion of a fibrillating dog
heart for one to two hours did not damage the subendo-
cardial muscle unless a strong maintained electrical stim-
Microvascular blood flow measured using laser Doppler  flowmetry in ischemic myocardium, after 20 minutes of  occlusion of the left anterior descending artery, exposed to  topical negative pressures of -25 mmHg and -50 mmHg Figure 3
Microvascular blood flow measured using laser Dop-
pler flowmetry in ischemic myocardium, after 20 
minutes of occlusion of the left anterior descending 
artery, exposed to topical negative pressures of -25 
mmHg and -50 mmHg. The measurements were per-
formed at a depth of 6–8 mm in the myocardium in six pigs. 
The results are shown as mean values ± SEM in the left panel. 
A level of *p < 0.05, **p < 0.01, and ***p < 0.001 was consid-
ered statistically significant. The right panel shows a repre-
sentative example of microvascular blood flow changes 
before and after application of -50 mmHg. Note the immedi-
ate blood flow response when negative pressure is applied.BMC Cardiovascular Disorders 2008, 8:14 http://www.biomedcentral.com/1471-2261/8/14
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ulus was used[21]. In the present study, no sustained
electrical stimuli was used, the ventricle was protected
from distension with a left ventricular vent, and the per-
fusion pressure was be kept at 80 mmHg, to avoid suben-
docardial ischemia in the fibrillating heart [22]. The effect
of TNP on the beating heart can not be deduced from the
present results, although we believe that the effect would
be similar to that observed here.
The future clinical application of myocardial TNP is still
too early to determine. However, the potential applica-
tion of myocardial TNP speculatively, in the future, might
become in the treatment of patients with extensive coro-
nary disease or/and refractory angina pectoris but also in
the acute phase of a ST-elevation myocardial infarction.
No-reflow sometimes occurs when using percutaneous
coronary intervention (PCI) to treat cases of acute ST-ele-
vation myocardial infarction. The treatment of estab-
lished no-reflow is mainly pharmacological, since the
obstruction occurs at the microvasculature level. Com-
pared with patients in whom no-reflow is transient, refrac-
tory no-reflow is associated with a markedly increased risk
of 30-day mortality[23,24]. To apply TNP at those areas in
the acute phase, with for example a trans-thoracic device,
might be useful for those patients. The method might
also, in the future, serve as an alternative treatment for
patients with extensive coronary artery disease, since,
VEGF proteins, that are also stimulated by TNP[25,26],
have been shown to play a key role in the modulation of
angiogenesis and vascular growth [27]. A transthoracic
device without CPB would be needed. Patients with
refractory angina pectoris represent a clinical challenge
due to the absence of a proven effective treatment. Many
different therapies have been tried, such as percutaneous
myocardial laser revascularization[28], and enhanced
external counter-pulsation[29], with varying results. Ther-
apeutic angiogenesis, wherein exogenous growth factors
are administered to ischemic tissue to enhance collateral
vessel formation and reperfusion, have also been investi-
gated as a potential form of treatment for these patients.
However, despite promising laboratory results, clinical
studies have not shown any clear benefit. Vascular
endothelial growth factor (VEGF) proteins have been
shown to play a key role in the modulation of angiogen-
esis and vascular growth[27]. Interestingly, TNP produces
a mechanical shear stress that is known to activate endog-
enous VEGF[25,26].
Conclusion
In conclusion, TNP of -25 mmHg and -50 mmHg both
induce a significant increase in microvascular blood flow
in normal and in ischemic myocardium. Moreover, the
increase in microvascular blood flow was larger when
using a TNP of -25 mmHg on normal myocardium, and
was larger when using a TNP of -50 mmHg on ischemic
myocardium, however these differences were not statisti-
cally significant, and might therefore be analyzed with
caution. From our perspective a topical negative pressure
of -50 mmHg might be more favourable as optimal myo-
cardial TNP than -25 mmHg.
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